Concor 5(Concor 5 mg)
Bisoprolol fumarate
Concor 5 and Concor 5 mg are different trade names for the same medicine.
important information for the patient.
The active substance of Concor 5 is bisoprolol fumarate. Bisoprolol belongs to a group of medicines called beta-blockers. These medicines affect the body's response to certain nerve impulses, especially in the heart. As a result, bisoprolol slows down the heart rate and increases the efficiency of the heart in pumping blood throughout the body. Bisoprolol at doses of 5 mg and 10 mg lowers high blood pressure.
Concor 5 is used to treat high blood pressure or coronary heart disease (chest pain caused by insufficient blood supply to the heart).
Do not take Concor 5 in the following cases:
If you have any of the following conditions, you should discuss them with your doctor before taking Concor 5; your doctor may decide that special caution is needed (e.g., additional medications or more frequent medical check-ups):
In addition, you should tell your doctor if you are planning:
Concor 5 is not recommended for children and adolescents.
You should tell your doctor about all medicines you are currently taking or have recently taken, as well as any medicines you plan to take.
Do not take the following medicines with Concor 5 without special advice from your doctor:
Before taking the following medicines with Concor 5, you should discuss them with your doctor, as your doctor may recommend more frequent medical check-ups:
Concor 5 and certain other medicines used to treat arrhythmias (class III antiarrhythmic agents, such as amiodarone);
There is a risk that taking Concor 5 during pregnancy may harm the baby.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a baby, you should ask your doctor or pharmacist for advice before taking this medicine.
Your doctor will decide whether you can take Concor 5 during pregnancy.
It is not known whether bisoprolol passes into human milk, so breastfeeding is not recommended during treatment with Concor 5.
The medicine may affect your ability to drive or use machines, depending on how well you tolerate it.
You should be particularly careful at the beginning of treatment, after increasing the dose, or when changing medicines, as well as when combining the medicine with alcohol.
This medicine should always be taken exactly as your doctor has told you.
If you are unsure, you should ask your doctor or pharmacist.
Concor 5 (5 mg) and Concor 10 (10 mg) are available.
Regular medical check-ups are necessary during treatment with Concor 5.
This is especially important at the beginning of treatment, when increasing the dose, and when stopping treatment.
The tablet should be taken in the morning with food or independently of food, with a glass of water.
The tablets should not be crushed or chewed.
In both indications, the usual dose is one Concor 5 tablet or half a Concor 10 tablet (equivalent to 5 mg of bisoprolol fumarate) once daily.
If necessary, your doctor may increase the dose to one Concor 10 mg tablet or two Concor 5 mg tablets (equivalent to 10 mg of bisoprolol fumarate) once daily.
The maximum recommended dose is 20 mg once daily.
In patients with mild to moderate liver or kidney impairment, there is usually no need to adjust the dosage.
In patients with severe kidney or liver impairment, the dose should not exceed 10 mg of bisoprolol per day.
Experience with bisoprolol in patients undergoing dialysis is limited; however, there is no evidence to suggest that the dosage needs to be adjusted.
Dose adjustment is not necessary.
Concor 5 is not recommended for children and adolescents.
Treatment with Concor 5 is usually long-term.
If treatment needs to be stopped, your doctor will usually recommend gradual reduction of the dose, otherwise, the disease may worsen.
If you have taken more Concor 5 than you should, you should immediately inform your doctor.
Your doctor will decide what actions to take.
Overdose symptoms include: slow heart rate, difficulty breathing, significant drop in blood pressure, dizziness, or seizures (caused by low blood sugar levels).
You should not take a double dose to make up for a missed dose.
The next morning, you should take the prescribed dose.
You should never stop taking Concor 5 unless your doctor tells you to.
Otherwise, the disease may worsen.
If you have any further doubts about taking this medicine, you should consult your doctor or pharmacist.
Like all medicines, Concor 5 can cause side effects, although not everybody gets them.
Frequent(occurring in less than 1 in 10 patients)
* These symptoms occur mainly at the beginning of treatment. They are usually mild and disappear within 1-2 weeks.
Uncommon(occurring in less than 1 in 100 patients)
Rare(occurring in less than 1 in 1,000 patients)
Very rare(occurring in less than 1 in 10,000 patients)
If you experience any side effects, including any not listed in this leaflet, you should tell your doctor or pharmacist.
Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products:
Jerozolimskie Avenue 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl
By reporting side effects, you can help provide more information on the safety of this medicine.
The medicine should be stored out of sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging.
The expiry date refers to the last day of the month stated.
Store in a temperature below 30°C.
Medicines should not be disposed of via wastewater or household waste.
You should ask your pharmacist how to dispose of medicines that are no longer needed.
This will help protect the environment.
Concor 5 film-coated tablets are yellowish-white, heart-shaped, with a dividing line.
PVC/Al blisters in a cardboard box.
The pack contains 30, 60, or 90 film-coated tablets.
For more detailed information, you should contact the marketing authorization holder or the parallel importer.
Merck Serono SIA
Duntes iela 23A
LV-1005 Riga
Latvia
Merck Healthcare KGaA
Frankfurter Strasse 250
64293 Darmstadt
Germany
Merck S.L.
Polígono Merck
08100 Mollet del Vallès (Barcelona)
Spain
Medezin Sp. z o.o.
Zbąszyńska Street 3
91-342 Łódź
Medezin Sp. z o.o.
Zbąszyńska Street 3
91-342 Łódź
Marketing authorization number in Latvia, the country of export: 99-0010
Parallel import authorization number: 11/25
[Information about the trademark]
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.